Health ❯ Mental Health ❯ Research

Clinical Trials

Psychedelic Research Exercise Studies Personalized Treatments Psilocybin Studies Phase II Trials Effectiveness Psychedelic-Assisted Therapy Psilocybin vs SSRIs Neuromodulation Research Therapeutic Efficacy

Study Finds THC Drops Cut PTSD Nightmares for Many Patients

The randomized trial published Aug. 5, 2026 shows nightly dronabinol sharply reduced nightmare burden without changing overall PTSD severity.

New Analysis Finds Psychedelic Therapy Matches Antidepressants for Major Depression

German Psilocybin Trial in Treatment-Resistant Depression Shows Modest Gains, Misses Main Goal

Lancet Psychiatry Review Finds No Mental-Health Benefit From Medicinal Cannabis

Large Study Flags Atypical Depression That Responds Poorly to Common Antidepressants

Updated Cochrane Review Finds Exercise Rivals Therapy for Depression

Meta-Analysis Finds Nitrous Oxide Offers Rapid, Short-Lived Relief for Depression

UK Psychiatrists Endorse Ketamine for Depression in Specialist Care

Astrocytic MAOB Overproduction Blocks Fear Extinction in PTSD; KDS2010 Advances to Phase 2 Trials

Survey Finds Cannabis and Psychedelics Most Effective for Eating Disorder Symptom Relief

JAMA Psychiatry Review Finds Mild Antidepressant Withdrawal, Gaps Noted for Long-Term Users

Home Brain Stimulation Headset Shows Promise in Treating Depression

Psilocybin Shown to Enhance Optimism in Rats, Offering Hope for Depression Treatment

Psilocybin Reduces Symptoms of Body Dysmorphic Disorder in Pilot Study